These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16148421

  • 21. Nesiritide: harmful or harmless?
    Dorsch MP, Rodgers JE.
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [Abstract] [Full Text] [Related]

  • 22. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA.
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [Abstract] [Full Text] [Related]

  • 23. Nesiritide (Natrecor): a new treatment for acutely decompensated congestive heart failure.
    Colbert K, Greene MH.
    Crit Care Nurs Q; 2003 May; 26(1):40-4. PubMed ID: 12669946
    [Abstract] [Full Text] [Related]

  • 24. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF, Holland R, Gyarmathy R, Dunbar L, Klapholz M, Horton DP, de Lissovoy G, Emerman CL.
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER, Najam S, Akel R, Sulimanjee N, Bionat S, Rosanio S.
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [Abstract] [Full Text] [Related]

  • 27. Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.
    Hiestand B, Abraham WT.
    Curr Cardiol Rep; 2007 May; 9(3):182-6. PubMed ID: 17470330
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA, Hernandez AF.
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [Abstract] [Full Text] [Related]

  • 29. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG, Redfield MM, Burnett JC, Chen HH.
    J Am Coll Cardiol; 2006 Jun 06; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.
    Hauptman PJ, Schnitzler MA, Swindle J, Burroughs TE.
    JAMA; 2006 Oct 18; 296(15):1877-84. PubMed ID: 17047218
    [Abstract] [Full Text] [Related]

  • 32. Nesiritide: trials and tribulations.
    Arora RR.
    J Cardiovasc Pharmacol Ther; 2006 Sep 18; 11(3):165-9. PubMed ID: 17056828
    [Abstract] [Full Text] [Related]

  • 33. Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.
    Abraham WT, Trupp RJ, Jarjoura D.
    Clin Cardiol; 2010 Aug 18; 33(8):484-9. PubMed ID: 20734445
    [Abstract] [Full Text] [Related]

  • 34. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL, Russell IA.
    J Cardiothorac Vasc Anesth; 2004 Dec 18; 18(6):780-7. PubMed ID: 15650995
    [No Abstract] [Full Text] [Related]

  • 35. Benefits, risks of heart failure drug questioned. The jury is still out on who needs nesiritide, a new heart failure drug, as well as what its risks are.
    Harv Heart Lett; 2005 Aug 18; 15(12):3. PubMed ID: 16200669
    [No Abstract] [Full Text] [Related]

  • 36. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials.
    Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K.
    JAMA; 2005 Apr 20; 293(15):1900-5. PubMed ID: 15840865
    [Abstract] [Full Text] [Related]

  • 37. Reliability of nesiritide infusion via non-primed tubing and heparin-coated catheters.
    Onat D, Stathopoulos J, Rose A, Newman K, Sciacca RR, Jorde UP, Colombo PC.
    Ann Pharmacother; 2005 Oct 20; 39(10):1617-20. PubMed ID: 16159995
    [Abstract] [Full Text] [Related]

  • 38. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT.
    Rev Cardiovasc Med; 2004 Oct 20; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [Abstract] [Full Text] [Related]

  • 39. Clinical improvement with repeated courses of intravenous B-type natriuretic peptide in refractory heart failure.
    Spevack DM, Matros T, Shah A, Dweck E, Tunick PA.
    Eur J Heart Fail; 2004 Aug 20; 6(5):611-3. PubMed ID: 15302009
    [No Abstract] [Full Text] [Related]

  • 40. Effect of nesiritide in patients with acute decompensated heart failure.
    O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalán R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Méndez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM.
    N Engl J Med; 2011 Jul 07; 365(1):32-43. PubMed ID: 21732835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.